NCT02164214View on ClinicalTrials.gov

Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

September 30, 2015

Conditions
Inflammatory RheumatismPsoriatic ArthritisRheumatoid Arthritis
Interventions
DRUG

etanercept Treatment

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02164214 - Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? | Biotech Hunter | Biotech Hunter